Investigation Overview
An investigation on behalf of current investors in AstraZeneca PLC (NYSE: AZN) over possible Securities Laws violations was announced. On February 26, 2009, AstraZeneca PLC agreed to unseal documents related to its multi-billion-dollar antipsychotic drug Seroquel concerning lawsuits pending in a U.S. federal court brought by thousands of plaintiffs alleging to be harmed by Seroquel. ...
You must register (for free) or login to view the entire investigation.